I wanted to give everyone an update and some pearls I learned at this weekend's Lyme Lecture.
The most important thing that I learned was how inaccurate the Quest or Labcorp or hospital blood tests are for diagnosing Lyme Disease. Apparently, there are two strains of Lyme and one strain has 8 species and the other has 5 species. That equals 13 different "bugs" that can cause Lyme Disease. Guess how many your basic Quest Lab test or hospital screening test will test for? One. Uno... That's pretty bad. So... If I or any other doctor has tested you for Lyme Disease in the past and did not test you using the newer Igenex IgG/IgM Immunoblot test, you should consider being restested especially if I or another practitioner is having trouble clearing all of your symptoms. The test to get is the Igenex IgM and IgG Immunoblot. It costs $450 unless you have Medicare which will pay for it. If you want to get this test done call the office at 248 302 0473 or email me at [email protected] The second pearl that I took away was treatming Lyme Disease with Disulfiram. This drug is usually used for alcoholism and if you drink any alcohol with it you will get violently ill. But apparently it kills spirochetes too. One reason they feel it may be effective is that it has a long half life: 60-120 hours. The treatment is for 3 months and you can have detox reactions from it as well. But... it apparently is working with relief of symptoms after the treatment. Here is a link to read more on this https://www.lymedisease.org/disulfiram-kinderlehrer/ Well, the above are the best pearls from the conference. Watch out for those ticks...
0 Comments
Stem cells are undifferentiated cells that can transform into specialized cells such as heart, neurons, liver, lung, skin and so on, and can also divide to produce more stem cells.
In a child or young adult, these stem cells are in large supply, acting as a built-in repair system. They are often summoned to the site of damage or inflammation to repair and restore normal function. But as we age, our supply of stem cells begins to diminish as much as 100- to 10,000-fold in different tissues and organs. In addition, stem cells undergo genetic mutations, which reduce their quality and effectiveness at renovating and repairing your body. What if you could restore and rejuvenate your stem cell population? One option to accomplish this restoration and rejuvenation is to extract and concentrate your own autologous adult stem cells from places like your adipose (or fat) tissue or bone marrow. These stem cells, however, are fewer in number and have undergone mutations (depending on your age) from their original ‘software code.’ Many scientists and physicians now prefer an alternative source, obtaining stem cells from the placenta or umbilical cord, the leftovers of birth. These stem cells, available in large supply and expressing the undamaged software of a newborn, can be injected into joints or administered intravenously to rejuvenate and revitalize. Think of these stem cells as chemical factories generating vital growth factors that can help to reduce inflammation, fight autoimmune disease, increase muscle mass, repair joints, and even revitalize skin and grow hair. Over the last decade, the number of publications per year on stem cell-related research has increased 40x. The stem cell market is expected to increase to $170 billion by 2020. Rising R&D initiatives to develop therapeutic options for chronic diseases and growing demand for regenerative treatment options are the most significant drivers of this budding industry. In a Stanford study, seven of 18 stroke victims who agreed to stem cell treatments showed remarkable motor function improvements. This treatment could work for other neurodegenerative conditions such as Alzheimer’s, Parkinson’s and ALS. Doctors from the USC Neurorestoration Center and Keck Medicine of USC injected stem cells into the damaged cervical spine of a recently paralyzed 21-year-old man. Three months later, he showed dramatic improvement in sensation and movement of both arms. In 2019, doctors in the U.K. cured a patient with HIV for the second time ever thanks to the efficacy of stem cells. After giving the cancer patient (who also had HIV) an allogeneic haematopoietic (e.g. blood) stem cell treatment for his Hodgkin’s lymphoma, the patient went into long-term HIV remission — 18 months and counting at the time of the study’s publication Learn more about Umbilical Cord Stem Cell Therapies |
Keri Topouzian, D.O.Dr. T specializes in holistic, functional, common sense medicine. Check out his new medical book on this website and his webinar Series. Archives
May 2024
Categories |